← Leaderboards
Leslie J. Berg
Univ Of Massachusetts Med Sch Worcester
$20,585,080
Attributed
$24,108,112
Total exposure
16
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,438,052 · 15
CDC$670,060 · 1
By mechanism
R01$23,521,908 · 12
P30$386,568 · 1
R21$175,636 · 1
R13$24,000 · 2
Top collaborators
- Joonsoo Kang6 shared
- Eric S Huseby5 shared
- Amy H Andreotti3 shared
Most similar at Univ Of Massachusetts Med Sch Worcester
Same institution · by research overlap
- Eric S Huseby$7,301,178
- Joonsoo Kang$16,196,546
- Celia A. Schiffer$33,871,325
Others in their field
Top investigators on “T-Lymphocyte”
- Barton F Haynes · Duke University$296,833,570
- Lawrence Corey · Fred Hutchinson Cancer Center$270,341,865
- Dan H. Barouch · Fred Hutchinson Cancer Center$117,305,894
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$107,651,960
- Alessandro Sette · La Jolla Institute For Immunology$75,756,097
- Rama Rao Amara · Emory University$69,530,112
Research focus
T-LymphocyteCellsProtein Tyrosine KinaseBaseResponsePathway InteractionsSignal TransductionCytokineInfectionSignal PathwayEffector CellVirus DiseasesT-Cell ActivationTec Protein Tyrosine KinaseAntigensPlayInsightProgramsIn VivoImmunityImmune ResponseTranscription FactorLaboratory MouseT Cell Response
Grant awards (71)
Structural Studies of a T cell Specific Tyrosine Kinase$535,619
R01 · FY2025 · AI
TCR signaling control of thymic Treg selection and immune homeostasis$575,269
R01 · FY2024 · AI
Structural Studies of a T cell Specific Tyrosine Kinase$562,986
R01 · FY2024 · AI
TCR signaling control of thymic Treg selection and immune homeostasis$577,145
R01 · FY2023 · AI
TCR signaling control of thymic Treg selection and immune homeostasis$578,865
R01 · FY2022 · AI
Dissecting the pathways controlling tunable responses to TCR signaling$478,861
R01 · FY2022 · AI · contact PI
TCR signaling control of thymic Treg selection and immune homeostasis$580,443
R01 · FY2021 · AI
Dissecting the pathways controlling tunable responses to TCR signaling$478,861
R01 · FY2021 · AI · contact PI
TCR signaling control of thymic Treg selection and immune homeostasis$598,876
R01 · FY2020 · AI
Dissecting the pathways controlling tunable responses to TCR signaling$406,354
R01 · FY2020 · AI · contact PI
Dissecting the pathways controlling tunable responses to TCR signaling$29,854
R01 · FY2020 · AI · contact PI
Dissecting the pathways controlling tunable responses to TCR signaling$324,045
R01 · FY2019 · AI · contact PI
Dissecting the pathways controlling tunable responses to TCR signaling$215,436
R01 · FY2019 · AI · contact PI
Dissecting the pathways controlling tunable responses to TCR signaling$539,481
R01 · FY2018 · AI · contact PI
Regulation of anti-viral T cell responses by IRF4$418,750
R01 · FY2017 · AI · contact PI
Plasticity of T helper cell differentiation$418,750
R01 · FY2016 · AI · contact PI
Regulation of anti-viral T cell responses by IRF4$418,750
R01 · FY2016 · AI · contact PI
ITK: an emerging target for treatment of T cell-mediated autoimmune disease$567,298
R01 · FY2015 · AI
Regulation of anti-viral T cell responses by IRF4$418,750
R01 · FY2015 · AI · contact PI
Plasticity of T helper cell differentiation$418,750
R01 · FY2015 · AI · contact PI
ITK: an emerging target for treatment of T cell-mediated autoimmune disease$567,298
R01 · FY2014 · AI
Plasticity of T helper cell differentiation$418,333
R01 · FY2014 · AI · contact PI
Regulation of anti-viral T cell responses by IRF4$418,126
R01 · FY2014 · AI · contact PI
ITK: an emerging target for treatment of T cell-mediated autoimmune disease$533,260
R01 · FY2013 · AI
Plasticity of T helper cell differentiation$391,079
R01 · FY2013 · AI · contact PI
Regulation of conventional versus innate CD8+ T cell development$382,709
R01 · FY2013 · AI · contact PI
ITK: an emerging target for treatment of T cell-mediated autoimmune disease$567,298
R01 · FY2012 · AI
Regulation of conventional versus innate CD8+ T cell development$407,138
R01 · FY2012 · AI · contact PI
ITK: an emerging target for treatment of T cell-mediated autoimmune disease$567,525
R01 · FY2011 · AI
Regulation of conventional versus innate CD8+ T cell development$407,138
R01 · FY2011 · AI · contact PI
FASEB SRC on Signal Transduction in the Immune System$15,000
R13 · FY2011 · AI · contact PI
Regulation of conventional versus innate CD8+ T cell development$411,250
R01 · FY2010 · AI · contact PI
Immunobiology of Jak3 Deficient Mice$344,794
R01 · FY2010 · AI · contact PI
Screening for inhibitors of the T cell Tec kinase, ltk$175,636
R21 · FY2010 · NS · contact PI
Tec Kinases ltk and RlK in Mast Cell Signaling$386,974
R01 · FY2009 · AI · contact PI
Immunobiology of Jak3 Deficient Mice$348,277
R01 · FY2009 · AI · contact PI
Tec family tyrosine kinases in T cell signaling$340,093
R01 · FY2009 · AI · contact PI
Tec Kinases ltk and RlK in Mast Cell Signaling$386,974
R01 · FY2008 · AI · contact PI
Immunobiology of Jak3 Deficient Mice$348,277
R01 · FY2008 · AI · contact PI
Tec family tyrosine kinases in T cell signaling$340,093
R01 · FY2008 · AI · contact PI
Tec Kinases ltk and RlK in Mast Cell Signaling$394,469
R01 · FY2007 · AI · contact PI
Immunobiology of Jak3 Deficient Mice$355,022
R01 · FY2007 · AI · contact PI
Tec family tyrosine kinases in T cell signaling$346,679
R01 · FY2007 · AI · contact PI
Response to viral infection in immunodeficient mice$280,510
R01 · FY2007 · CI · contact PI
Tec Kinases ltk and RlK in Mast Cell Signaling$405,833
R01 · FY2006 · AI · contact PI
Response to viral infection in immunodeficient mice$389,550
R01 · FY2006 · CI · contact PI
Immunobiology of Jak3 Deficient Mice$365,156
R01 · FY2006 · AI · contact PI
Tec family tyrosine kinases in T cell signaling$356,576
R01 · FY2006 · AI · contact PI
Tec family tyrosine kinases in T cell signaling$364,500
R01 · FY2005 · AI
Response to viral infection in immunodeficient mice$0
R01 · FY2005 · CI
IMMUNOBIOLOGY OF JAK3-DEFICIENT MICE$281,516
R01 · FY2004 · AI
Response to viral infection in immunodeficient mice$0
R01 · FY2004 · CI
THYMIC SELECTION AND T CELL LINEAGE COMMITMENT$293,046
R01 · FY2003 · AI
T CELL DEVELOPMENT AND THE TYROSINE KINASE, ITK/TSK$286,256
R01 · FY2003 · AI
IMMUNOBIOLOGY OF JAK3-DEFICIENT MICE$273,403
R01 · FY2003 · AI
Response to viral infection in immunodeficient mice$0
R01 · FY2003 · CI
THYMIC SELECTION AND T CELL LINEAGE COMMITMENT$284,596
R01 · FY2002 · AI
IMMUNOBIOLOGY OF JAK3-DEFICIENT MICE$265,528
R01 · FY2002 · AI
T CELL DEVELOPMENT AND THE TYROSINE KINASE, ITK/TSK$263,702
R01 · FY2002 · AI
FASEB Summer Research Conference: Lymphocytes/Antibodies$9,000
R13 · FY2002 · AI
CORE--TRANSGENIC/KNOCKOUT ANIMAL FACILITY$0
P30 · FY2002 · DK
T CELL DEVELOPMENT AND THE TYROSINE KINASE, ITK/TSK$269,996
R01 · FY2001 · AI
IMMUNOBIOLOGY OF JAK3-DEFICIENT MICE$257,882
R01 · FY2001 · AI
THYMIC SELECTION AND T CELL LINEAGE COMMITMENT$257,321
R01 · FY2001 · AI
CORE--TRANSGENIC/KNOCKOUT ANIMAL FACILITY$193,284
P30 · FY2001 · DK
CORE--TRANSGENIC/KNOCKOUT ANIMAL FACILITY$0
P30 · FY2001 · DK
CORE--TRANSGENIC/KNOCKOUT ANIMAL FACILITY$0
P30 · FY2001 · DK
IMMUNOBIOLOGY OF JAK3-DEFICIENT MICE$308,458
R01 · FY2000 · AI
T CELL DEVELOPMENT AND THE TYROSINE KINASE, ITK/TSK$262,221
R01 · FY2000 · AI
THYMIC SELECTION AND T CELL LINEAGE COMMITMENT$249,909
R01 · FY2000 · AI
CORE--TRANSGENIC/KNOCKOUT ANIMAL FACILITY$193,284
P30 · FY2000 · DK